Position in PGEN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,186,603
+$1,186,603 QoQ
Shares Held
306,616
Ownership
0.086%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Derivatives in PGEN
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$5,805,000
PutShares
1,500,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Caption Management, LLC holds $196,103,961 across 70 Biotechnology names. PGEN ranks #28 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
378,480 | $25,615,526 | |
| 2 | IMCR |
Immunocore Holdings plc
|
661,786 | $19,952,847 | |
| 3 | CYTK |
Cytokinetics Inc
|
245,000 | $16,147,950 | |
| 4 | ELVN |
Enliven Therapeutics, Inc.
|
370,000 | $14,504,000 | |
| 5 | SLNO |
Soleno Therapeutics Inc
|
420,143 | $14,066,387 | |
| 6 | CNTA |
Centessa Pharmaceuticals plc
|
274,116 | $10,887,887 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
260,000 | $10,480,600 | |
| 8 | HRMY |
Harmony Biosciences Holdings, Inc.
|
272,292 | $7,626,898 |
All Filings in PGEN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,186,603 | 306,616 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $5,805,000 | 1,500,000 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $4,598,000 | 1,100,000 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $11,177,775 | 3,397,500 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $3,717,700 | 1,130,000 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $142,000 | 100,000 | Call | Sole | 2025-08-14 | |
| 2022-12-31 | $304,000 | 200,000 | Call | Sole | 2023-02-14 | |
| 2022-09-30 | $424,000 | 200,000 | Call | Sole | 2022-11-14 | |
| 2022-06-30 | $268,000 | 200,000 | Call | Sole | 2022-08-15 | |
| 2022-03-31 | $675,200 | 320,000 | Call | Sole | 2022-05-13 | |
| 2022-03-31 | $337,600 | 160,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $44,082 | 11,882 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $59,291 | 11,882 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $77,470 | 11,882 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $81,866 | 11,882 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $476,533 | 46,719 | Shares | Sole | 2021-02-16 | |
| 2020-12-31 | $1,108,740 | 108,700 | Put | Sole | 2021-02-16 | |
| 2020-09-30 | $22,750 | 6,500 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $32,435 | 6,500 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $22,100 | 6,500 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||